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Introduction
The World Health Organization aims at promoting initiatives 
focused on the preservation of individuals’ physical and mental 
capacities to achieve older ages in a good health status (healthy 
aging, defined as “the process of developing and maintaining 
the functional ability that enables well-being”) (1). Intrinsic 
capacity is a new term launched in the WHO in the plan of 
action 2016-2020 (1). The operational definition of “intrinsic 
capacity” is “the composite of all the physical and mental 
capacities of an individual” and is constructed by 5 domains: 
locomotion, vitality, sensory (vision and hearing), cognition, 
and psychological domain (2). Intrinsic capacity has a positive 
value, is focused on function, and switches the viewpoint from 
a negative paradigm of ageing (diseases, disability, frailty, etc.) 
towards the positive focus of a “healthy aging” (2,3). 
The Integrated Care for Older People (ICOPE) program was 
launched by the WHO n. Global strategy and action plan on 
ageing and health in 2016 (4) and is focused on individuals’ 
comprehensive assessment and potential interventions 
on the 5 domains of intrinsic capacity (5, 6). In a second 
step, the strategy the WHO is aimed on providing evidence 
about trajectories of life (Normograms for Healthy Ageing 
Standards). The WHO plan of action scheduled for 2020-
2030 would provide the continuity of this line of research 
(https://www.who.int/ageing/en/). The WHO guidelines on 
community-level interventions in integrated care have been 
recently launched, aimed at “Redesigning care for older people 
to preserve physical and mental capacity”, and involve the 
comprehensive assessment of the domains of intrinsic capacity 
(5, 6). 
Two new technologies for the assessment of intrinsic 
capacity are available and capable to screen for individual’s 
intrinsic capacity (7, 8): The ICOPE application (App) has 
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been developed by WHO and the ICOPE Monitor, has been 
developed as part of the INSPIRE program, an initiative from 
the Gérontopôle of Toulouse, which is a WHO Collaborating 
Center, in collaboration with the WHO and several partners 
from Toulouse (7, 8). The two Apps are already available free-
of-charge in Apple or Android Store. 
Frailty, defined as a “syndrome characterized by a 
clinical state in which there is an increase in an individual’s 
vulnerability for developing an increased dependency and/or 
mortality when exposed to a stressor” (9), is also a construct 
of several domains (10, 11). Despite frailty is a different 
construct, it would be expected that a decrease in intrinsic 
capacity, measured by the Apps is associated to the occurrence 
of frailty and functional decline, but these associations remain 
unexplored (3).  
We hypothesize that intrinsic capacity, assessed by the 
ICOPE App and ICOPE Monitor at baseline, could identify 
individuals at higher risk of developing frailty, functional 
decline, and health adverse outcomes during 1-year follow-
up. If these hypotheses are confirmed, ICOPE Apps could be 
incorporated into clinical practice in community-dwelling older 
people.  
Objectives: Our primary objective is to assess the 
relationship between intrinsic capacity assessed with the ICOPE 
Apps (ICOPE App and ICOPE Monitor) at baseline and the 
incidence of frailty in community-dwelling older adults during 
1-year follow up. Secondarily, to assess the association between 
intrinsic capacity measured by the ICOPE App and the ICOPE 
Monitor at baseline and the risk of functional decline, mortality, 
incidence of pre-frailty, falls, institutionalization, and loss of 





Protocol for a prospective cohort study, designed to 
determine the incidence of frailty in community-dwelling 
older people during 1-year follow-up. The Strengthening 
the Reporting of Observational Studies in Epidemiology 
(STROBE) statement (12) will be followed. Subjects who 
volunteer and meet eligibility criteria will be consecutively 
included. 
Settings 
The study will be conducted in Liège, a city located in 
the French-speaking region of Belgium. Volunteers will be 
recruited from 1) the Geriatric Department of the university 
hospital, 2) Outpatient clinics of primary care, and 3) Local 
press, television, and radio advertisements. In the first two 
options, the clinicians in the Geriatrics or primary care 
department that collaborate with the study, would identify a 
potential candidate and send an electronic mail with contact 
details to the personal from the study. In the third option, 
volunteers will receive instructions to proactively contact by 
telephone or electronic mail (e-mail) with the personal from 
the study. After receiving the e-mails, a telephone or video-
call between the volunteer and the personal from the study 
will be scheduled in a maximum of 1 week. During the first 
interview, subjects will be assessed for eligibility, receive 
detailed information about the study, and sign electronically 
the informed consent by drawing their own signature in the 
screen of the mobile and forwarding it as an image. A printed 
copy of the informed consent with the signature in paper 
will be sent to volunteers’ homes by post mail afterward. 
Technical assistance in downloading the two Apps, signing the 
informed consent, the baseline assessment, and schedule next 
follow-up will be given during the first interview. The 4-, 8-, 
and 12-month follow-up will be conducted in a similar way. 
The Geriatric and primary care Department count with the 
technical devices and facilities to conduct the proposed test, 
and the Apps are free-of-charge (Apple /Android Store https://
www.youtube.com/watch?v=gLva4ReV9KA). Data will be 
analysed at the Research Unit in Biostatistics, Public Health 
Department, University of Liege, Belgium. Table 1 summarizes 
study settings, variables, and timeline of the study.
Population
Prospective cohort study of community-dwelling adults 
≥65-year-old living at home, with no other exclusion criteria 
than the inability to use the ICOPE Apps or communicate by 
telephone/video-call for any reason (cognitive or limited access 
to technologies like telephone/video-call) OR being considered 
frail at baseline (defined as having a Rockwood’s clinical frailty 
scale, CFS score ≥4). 
Intrinsic capacity assessment: Will be administered with the 
two Apps, the ICOPE App and the ICOPE Monitor.
ICOPE App: The screening by ICOPE App includes polar 
questions (yes/no) about the 5 domains of intrinsic capacity. 
Two results are possible: positive (probable decrease in intrinsic 
capacity) or negative (intrinsic capacity not decreased), as a 
total binary result of the 5 domains together. The App includes 
possibility to record the summary of the screening, download it 
in pdf, or send it by mail.
ICOPE Monitor: For the moment, ICOPE Monitor is 
equipped with ICOPE Step 1 (i.e. screening tool). ICOPE 
Monitor includes identification and informed consent of both 
the professional and the participant, detailed intrinsic capacity 
assessment of the 5 domains and reports the results obtained 
in each one of the 5 domains separately afterwards. The results 
obtained in the 5 domains are provided as a checklist: two 
results are possible for each one of the 5 domains: “right” or 
“wrong” in each domain. Updated advice for each domain 
and a link for further information is also provided. The App 
automatically schedules the date for the next 4-month follow-up 
and sends the informed consent by mail to the volunteer.
The results in the two Apps provide different approaches to 
IC. First, a global binary decision (IC decline or not) is directly 
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provided by the ICOPE App (IC decline or not). Second, a 
binary decision of each one of the 5 domains per separate 
is provided directly by the ICOPE Monitor (each domain 
decreased or not); third, the binary decision obtained in the 
5-domains could be combined as a score which might be just 
a count of IC declines, e.g. if we have 3 domains with decline 
among the 5 domains, the score would be 3/5. For purpose of 
this analysis, the second approach, a binary decision of each 
one of the 5 domains per separate provided directly by the 
ICOPE will be selected; the other two options would be studied 
as part of further secondary analysis.
Outcome measures
Primary outcome measure: Incidence of frailty assessed by 
Rockwood’s clinical frailty scale (CFS) will be assessed at 
baseline, 4-, 8- and 12-month follow-up by telephone/video-
call. An score <4 will indicate robustness, 4-6 pre-frailty status, 
and ≥ 6 frailty  (10). Secondary outcome measures: Incidence 
of functional decline (assessed by Chair stand test (14,15) 
and the loss of ≥20 points in Barthel index (16,17), death 
(date), incidence of pre-frailty (assessed by CFS) (10), falls 
(number and date), institutionalization (date), and quality of life 
(EuroQol) (18) will be assessed at 4-, 8-, and 12-month follow-
up by a telephone/video-call with the volunteer or a contact 
person.
Functional decline: Incidence of functional decline will 
Table 1
Variables, study settings, and timeline
Baseline 4-month follow-up 8-month follow-up 12-month follow-up 
(end-point)












Primary outcome: Incidence of frailty 
by Rockwood’s Clinical Frailty Scale 
(CFS) 
- x x x x
Secondary outcome measures: x x x x
- Functional decline (Chair Stand Test 
OR loss of ≥20 points of Barthel index)
- x x x x
- Death (date) - x x x x
- Pre-frailty in CFS - x x x x
- Falls (number and date) - x x x x
- Institutionalization (date) - x x x x
- Quality of life (EuroQol) - x x x x
Intrinsic capacity assessment (screening)
ICOPE App - x x x x
ICOPE Monitor - x x x x
Functional status 
Instrumental activities of daily living 
(Lawton index)
- x x x x
Basic activities of daily living (Barthel 
index)
- x x x x
Clinical and demographic variables - x x x x
Technological, Economical, Legal, 
Operational, Schedule (TELOS)-
feasibility score
- x - - x
Identification of possible candidates, 
volunteers’ information 
x - - - -
Volunteers’ information, sign 
electronically the informed consent, 
and consent form collection
- x - - -
a. Statistical analysis will be conducted at the Research Unit in Biostatistics, Public Health Department, University of Liege, Belgium; The sign “x” means test or probe 
performed and registered; the sign “-“means test not performed.
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be defined as 1) The loss of the capacity to raise from a chair 
within 14 seconds, measured by the chair stand test in the 
ICOPE Monitor (Chair stand test) (14, 15); or 2) The loss of at 
least one activity of daily living, defined as loss of ≥20 points in 
Barthel index (16, 17), administered by phone (19) at baseline, 
4-, 8- and 12-month follow-up (16, 17, 19, 20).
Death: Date of death will be recorded, reported by the 
contact person if the participant did not respond to the 
scheduled follow-up visit at 4-, 8-, and 12-month follow-up. 
Pre-frailty: Incidence of pre-frailty will be assessed by CFS 
at baseline, 4-, 8- and 12-month follow-up by telephone/video-
call. An score <4 will indicate robustness, 4-6 pre-frailty status, 
and ≥6 frailty  (10).
Falls (number and date) will be recorded by the volunteers 
on a personal dairy book. 
Institutionalization: Date of institutionalization will be 
reported by the contact person if the participant did not respond 
to the scheduled follow-up.
Quality of life will be measured by self-reported EuroQol 
(ranging from 0 -the worst possible health status- to 1 -the best 
possible health status-) (18) by telephone/video-call at baseline, 
4-, 8-, and 12-month follow-up.
Covariate data collection: Demographic and clinical data 
will be collected during the telephone/video calls and used 
as covariates. Instrumental activities of daily living (IADL) 
(maximum score 8 points) will be recorded using the Lawton 
scale (21). The ratio of the total score obtained / total score of 
the applicable items will be used to avoid any discrimination 
based on usual housework distribution among couple as in 
Gillain et al., 2017. E.g. if one of the members of a couple does 
not usually perform an activity, that item will not account for 
that individual, then, the total score of the applicable items will 
be 7 instead of 8 (22).
Feasibility of the ICOPE App and ICOPE Monitor: 
Feasibility will be defined as “the state or degree of being easily 
or conveniently done” and explored by the Technological, 
Economical, Legal, Operational, Schedule (TELOS)-feasibility 
score, which assesses the potential of implementation of new 
systems, and considers them feasible if TELOS-feasibility score 
≥3) (23). It will be administered to the geriatric and primary 
care practitioners who collaborate with the study.
Sample size calculation 
Sample size has been calculated in terms of the ICOPE 
study primary objective: to identify incidence of frailty in 
community-dwelling older patients. Table 2 shows the sample 
size calculation determined by a power calculation based on 
the width of the confidence interval for a proportion and on the 
estimation of an incidence rate (24). Assuming a prevalence of 
frailty of 10.7% (25), an incidence of 13% (26) with an alpha 
risk of 0.05, we estimated that 400 participants at the 12-month 
end-point of the study would be necessary to meet a degree of 
certainness regarding the incidence (relative precision of 0.10) 
meaning a sample of 600 volunteers at baseline should be cover 
a potential large dropout regarding the characteristics of this 
study (observational, 1-year follow-up, potential frail people, 
unknown adherence rate to the follow-up).  
Statistical plan
Descriptive analysis will be performed for each variable 
of the study. Qualitative variables will be described by 
absolute numbers and relative frequencies (%). Quantitative 
variables will be summarized by the use of means and standard 
deviation (SD) for symmetrical distribution or median and 
the interquartile deviation for asymmetrical distributions. 
Normality of variables will be checked graphically with 
histograms and quantile-quantile plots, and tested by the 
Shapiro-Wilk test. A transformation of the data might be 
performed, if needed. 
The evolution of intrinsic capacity during the 1-year follow-
Table 2
Sample size calculation according to the prevalence and expected incidence of frailty
Prevalence of 10.7% Incidence 13% with α = 0.05
Precision (Δ) 95% Confidence Interval Number of subjects Relative precision (ε) Number of subjects
1% 9.7% - 11.7% 3671 0.05 1537
2% 8.7% - 12.7% 918 0.06 1068
3% 7.7% - 13.7% 408 0.07 785
4% 6.7% - 14.7% 229 0.08 601
5% 5.7% - 15.7% 147 0.09 475
6% 4.7% - 16.7% 102 0.10 385
7% 3.7% - 17.7% 75 0.12 267
8% 2.7% - 18.7% 57 0.14 197
9% 1.7% - 19.7% 45 0.20 97
10% 0.7% - 20.7% 37 0.30 43
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up will be analyzed by Generalized Linear Mixte Model 
(GLMM). These models will be also used to study the evolution 
of outcomes measured every 4 months and the impact of 
covariates on these evolutions.  Kaplan-Meier methods will be 
use to represent graphically the notion of time occurrence of 
frailty and mortality (4-month follow-up time will be used as 
notion of time). 
For the outcomes with a precise date of event (frailty, 
mortality, falls, institutionalization), their association with 
intrinsic capacity will be analyzed by a joint model for 
longitudinal and time-to-event data (27); the same analysis 
might be performed for other variables of interest, if required. 
Indeed, on one hand, we want to analyze the evolution over 
time of covariates and on the other hand the effect of these 
covariates on the outcome. Multiple imputations methods 
would be applied to deal with missing data. The data will be 
processed using SAS 9.4 (©SAS Institute Inc., Cary, NC, USA) 
and R (version 3.5) (R Core Team) software packages. The 
level of statistical significance will be set as α = 5% (p < 0.05).
Ethics
National and International research Ethics guidelines will 
be followed, including the 1964 Declaration of Helsinki and its 
further amendments, and the Committee on Publication Ethics 
(COPE) guidelines (28)(29). Data will be treated according to 
the law of data protection in Belgium and the Regulation (EU) 
2016/679 of the European Parliament and of the Council of 
27 April 2016 on the protection of natural persons with regard 
to the processing of personal data (30). The approval of the 
Ethics Committee (Comité d’Ethique Hospitalo-Facultaire 
Universitaire de Liège) will be obtained. Written and oral 
information will be provided and informed consent will be 
signed electronically by all participants. The study has been 




Our study will determine the associations among decrease 
in intrinsic capacity and the incidence of frailty, functional 
decline, and occurrence of health adverse outcomes in 
community-dwelling older people during 1-year follow-up. If 
these associations are observed in the study, the measurement 
of intrinsic capacity by new technologies would be ready to be 
implemented in clinical practice. 
Several aspects of the study should be highlighted. First, it 
will include intrinsic capacity assessment (2). Indeed, even if 
the association of intrinsic capacity with mortality, functional 
decline, and falls was recently shown in older people in nursing 
homes (31), there is still very few data in community-dwelling 
population. The rationale to select intrinsic capacity, instead 
of using other syndromes or diseases, for example, sarcopenia, 
malnutrition, or dementia, is due to the multidimensional 
characteristics of older people, which require a global 
assessment. A single point of view might not be complete 
enough to take complex decisions in clinical practice. 
Second, the study will provide evidence about the 
relationship between intrinsic capacity and frailty, which is a 
different multidimensional construct. Wide differences among 
frailty and intrinsic capacity have been pointed out, i.e. frailty is 
driven by deficits, while intrinsic capacity is driven by reserves; 
frailty is an approach towards treatment usually measured in 
clinical settings, while intrinsic capacity is an approach focused 
on function maintenance in the community setting; frailty has 
wide evidence about its prognosis capacity, while intrinsic 
capacity is quite new. It would be expected that intrinsic 
capacity, measured by the Apps is associated to the incidence 
of frailty, but this association remains unexplored and requires 
further studies (3).
Three different approaches of IC will be explored, in order 
to provide novel insight about how to deal with IC as variable, 
which is still an uncharted territory; for purpose of analysis, 
the approach that uses a binary decision of each one of the 5 
domains per separate provided directly by the ICOPE will be 
selected, as it is effortless, obtained directly by the ICOPE 
Monitor, and provide insight to deliver potential therapeutic 
interventions. The other two options would be studied as part of 
further secondary analysis.
Mortality has been selected as clinically meaningful outcome 
of the study, as recommended by the Common data elements 
(CDE) and core outcome measures (COMs) in Frailty research 
consensus (32) and the Physical Frailty: ICFSR International 
Clinical Practice Guidelines for Identification and Management 
(33). Frailty has shown association with 2-fold higher all-
cause mortality (HR 2.17, 95%CI 1.90-2.48) (34), including 
infectious diseases (HR 1.79, 95%CI 1.03-3.11) (34). Sample 
size calculation was based on a prevalence of frailty of 10.7% 
(25) and incidence 13%, (26)(35). Despite lower incidence rates 
(3.9%, 8%)(35–37), have been shown in other large cohorts, 
the highest one was selected for our sample size calculation to 
ensure the detection of frailty (11). Providing data about the 
relationship between intrinsic capacity and frailty will pave the 
path towards the change in the negative paradigm of aging, and 
a person-centred model focused on enhancing the 5 domains 
towards healthy aging (3). 
Third, our study will include the use of new technologies 
by older people, which is an emerging field with promising 
results. Several projects on the use of technologies to support 
health status of older people are currently ongoing, e.g. the 
J48 supervised machine learning algorithm is identifies future 
fallers among otherwise healthy, independent older adults 
(38); eMIND is a randomized controlled trial that includes 
web-based multidomain interventions (39); and the ALLEGRO 
living lab is an experimental hospital-based room for the 
testing of devices by frail hospitalized older people (40). The 
International Network of Agencies for Health Technology 
Assessment (INAHTA) provides high quality evidence about 
new technologies to help health care suppliers and policy 
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makers in their decisions. The Belgian Health Care Knowledge 
Centre (KCE) has recently joined the INAHTA in 2020 (41), 
which might be promising for this line of research. 
Finally, some limitations related to the cohort design should 
be acknowledged. The inclusion of healthy community-
dwelling older volunteers will be considered as a selection 
bias, as it has been previously reported in other cohorts of 
community-dwelling older people (42). The characteristics of 
voluntary older participants (motivation, involvement in self-
care management, etc.) might differ from those who refused 
to get involved in a research study. Moreover, volunteers who 
are able to use online resources might be relatively younger 
at baseline, and their health status might be better than the 
population of the same age. 
In summary, this study will apply the “Action-research 
philosophy” (43) to bridge the gap between research and 
clinical practice. It will provide evidence to implement the 
ICOPE App and ICOPE Monitor, deliver efficient person-
centered care-plans, and benefit older adults, professionals, and 
the healthcare systems.
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